首页> 美国卫生研究院文献>Journal of Biomedical Science >Mechanism of inhibitory effect of atorvastatin on resistin expression induced by tumor necrosis factor-α in macrophages
【2h】

Mechanism of inhibitory effect of atorvastatin on resistin expression induced by tumor necrosis factor-α in macrophages

机译:阿托伐他汀抑制巨噬细胞肿瘤坏死因子-α诱导的抵抗素表达的机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Atorvastatin has been shown to reduce resistin expression in macrophages after pro-inflammatory stimulation. However, the mechanism of reducing resistin expression by atorvastatin is not known. Therefore, we sought to investigate the molecular mechanisms of atorvastatin for reducing resistin expression after proinflammatory cytokine, tumor necrosis factor-α (TNF-α) stimulation in cultured macrophages. Cultured macrophages were obtained from human peripheral blood mononuclear cells. TNF-α stimulation increased resistin protein and mRNA expression and atorvastatin inhibited the induction of resistin by TNF-α. Addition of mevalonate induced resistin protein expression similar to TNF-α stimulation. However, atorvastatin did not have effect on resistin protein expression induced by mevalonate. SP600125 and JNK small interfering RNA (siRNA) completely attenuated the resistin protein expression induced by TNF-α and mevalonate. TNF-α induced phosphorylation of Rac, while atorvastatin and Rac-1 inhibitor inhibited the phosphorylation of Rac induced by TNF-α. The gel shift and promoter activity assay showed that TNF-α increased AP-1-binding activity and resistin promoter activity, while SP600125 and atorvastatin inhibited the AP-1-binding activity and resistin promoter activity induced by TNF-α. Recombinant resistin and TNF-α significantly reduced glucose uptake in cultured macrophages, while atorvastatin reversed the reduced glucose uptake by TNF-α. In conclusion, JNK and Rac pathway mediates the inhibitory effect of atorvastatin on resistin expression induced by TNF-α.
机译:已显示阿托伐他汀在促炎刺激后可降低巨噬细胞中抵抗素的表达。但是,阿托伐他汀降低抵抗素表达的机制尚不清楚。因此,我们寻求研究在培养的巨噬细胞中促炎细胞因子,肿瘤坏死因子-α(TNF-α)刺激后阿托伐他汀降低抵抗素表达的分子机制。培养的巨噬细胞获自人外周血单核细胞。 TNF-α刺激增加抵抗素蛋白和mRNA表达,阿托伐他汀抑制TNF-α诱导抵抗素。甲羟戊酸诱导的抵抗素蛋白表达与TNF-α刺激相似。但是,阿托伐他汀对甲羟戊酸诱导的抵抗素蛋白表达没有影响。 SP600125和JNK小干扰RNA(siRNA)完全减弱了TNF-α和甲羟戊酸所诱导的抵抗素蛋白表达。 TNF-α诱导Rac磷酸化,而阿托伐他汀和Rac-1抑制剂抑制TNF-α诱导Rac磷酸化。凝胶转移和启动子活性测定表明,TNF-α增加了AP-1结合活性和抵抗素启动子活性,而SP600125和阿托伐他汀抑制了TNF-α诱导的AP-1结合活性和抵抗素启动子活性。重组抵抗素和TNF-α显着降低了培养的巨噬细胞的葡萄糖摄取,而阿托伐他汀逆转了TNF-α降低的葡萄糖摄取。总之,JNK和Rac途径介导阿托伐他汀对TNF-α诱导的抵抗素表达的抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号